AcaRevival Initiative

Experienced academic misconduct or bullying? We're building a real weapon against it.

Read Manifesto →
LH

Leif G. Hanitsch

Clinical Immunology

Freie Universität Berlin

No ratings yetBe the first to rate
Loading...

About Leif G. Hanitsch at Freie Universität Berlin

Leif G. Hanitsch is a researcher at Freie Universität Berlin, where they contribute to the Clinical Immunology Department. They specialize in Immunodeficiency, Autoimmune Disorders, and Fibromyalgia, with ongoing contributions to these areas. Their academic career is distinguished by over 4,068 citations, demonstrating their leading role in the global research community. With a formidable H-index of 30, Leif G. Hanitsch continues to drive innovation in their area of expertise.

Research Areas

ImmunodeficiencyAutoimmune DisordersFibromyalgiaChronic Fatigue SyndromeBlood DisordersCVIDTAFRO SyndromeAPDS

Academic Impact Matrix

Research output metrics for Leif G. Hanitsch aggregated from public academic databases. Student lab experience data is pending.

Academic data verified · April 2026 · Next sync: May 2026

Research Output

Total Citations4,068

Emerging researcher

Publications99

Selective publication record

h-index30

Established scholar

i10-index50

Growing portfolio

Lab Environment

No lab data yet for Leif G. Hanitsch

+ Contribute First Review
  • Supervisionawaiting data
  • Responsivenessawaiting data
  • Fundingawaiting data
  • Communicationawaiting data
  • Work-Life Balanceawaiting data

Reviews (0)

No reviews yet for this supervisor.

Be the first to share your experience!

Is your PI driving you crazy?

Featured Article

The Sunday Night Dread: Surviving a Micromanaging PhD Supervisor

Real advice from PhD students on recognizing and navigating difficult supervisor relationships

Your experience matters. After reading the guide, share your review to help other PhD students.

Frequently Asked Questions

Not sure how to interpret mixed signals? A structured decision guide can help you think through high-risk supervision choices more clearly. Download the free guide.